Meta-Analysis of Efficacy of Probiotic Supplementation in Children for Prevention and Treatment of Common Pediatric Illnesses

Acute gastroenteritis, respiratory tract infections, and antibiotic-associated diarrhea are common pediatric disorders that continue to be major sources of morbidity in children around the world (1), (2). Especially in low- and middle-income nations, these illnesses have a significant impact on healthcare use, school absences, and, in extreme situations, hospitalization and death (3). The burden of these diseases is still high despite improvements in treatment and preventative measures (4). Concerns about antibiotic resistance, disturbance of gut flora, and related side effects including antibiotic-associated diarrhea have also grown as a result of the extensive and frequently careless use of antibiotics in young populations (5). Growing interest in safe and efficient adjuvant therapy that may lower disease incidence, severity, and recurrence has been spurred by these difficulties (6), (7).

In this regard, probiotics which are defined as live microorganisms that help the host's health when given in sufficient quantities have shown great promise (8). Modification of the immune response, improvement of mucosal barrier function, competitive inhibition of pathogenic organisms, and gut microbiota stabilization are some of the suggested mechanisms of action (9), (10). Numerous strains have been studied for their possible use in the prevention and treatment of common pediatric diseases, especially those from the genera Lactobacillus and Bifidobacterium(11),(12).

Nevertheless, results from different clinical trials have varied, most likely as a result of variations in probiotic strains, dosages, study participants, and outcome measures (13). This variation emphasizes the necessity of a thorough pooled assessment (14), (15). In order to provide more precise information to guide clinical practice and future research, this meta-analysis attempts to methodically evaluate the effectiveness of probiotics in the prevention and treatment of common pediatric diseases.

•                      Study Design: Meta-analysis of 14 randomized controlled trials conducted in Esic medical college and hospital, Bihta, Patna.

•                      Population: Children aged 6 months–12 years

•                      Outcomes:

•                      Acute diarrhea incidence

•                      URTI incidence

•                      Antibiotic-associated diarrhea

•                      Duration of illness

•                       

Statistical Analysis:

The total effect size across trials was estimated using a pooled Risk Ratio (RR). The pooled RR was compared to the null value of 1 using a one-sample t-test, with p < 0.05 designated as the statistical significance level. Age and strain-based subgroup analyses were performed, and the I2 statistic was used to evaluate study heterogeneity.

Table 1: Pooled Effect Sizes

Table 2: Heterogeneity (I²)

Table 3: Subgroup Analysis by Probiotic Strain

Table 4: Subgroup Analysis by Age

Figure 1: Pooled risk ratio for probiotics supplements

Figure 2: Subgroup analysis by age

Probiotic supplementation dramatically lowers the incidence of acute diarrhea, URTI, and antibiotic-associated diarrhea in children, according to this meta-analysis. Preventing antibiotic-associated diarrhea had the biggest impact (RR=0.53). Additionally, probiotics reduced the length of illness by about 24% (16).  Age-dependent and strain-specific benefits are suggested by subgroup analysis, with younger children and Lactobacillus strains benefiting the most (17). Variation in research demographics, dose, and strains is reflected in moderate heterogeneity (18). Mechanistically, probiotics strengthen the integrity of the intestinal barrier, boost mucosal immunity, and combat harmful organisms (19), (20).

Every assessed outcome showed a statistically significant improvement, suggesting that the intervention had a constant protective impact across research (21). Although not significant enough to call into question the overall conclusions, moderate heterogeneity was noted, indicating some variation in study populations, methodology, or intervention characteristics (22),(23). According to subgroup analysis, some strains of Lactobacillus had a stronger protective effect than others. Furthermore, younger children showed a more noticeable improvement, suggesting that the intervention may have age-dependent efficacy (24), (25).

These results corroborate recent pediatric guidelines that advocate the use of probiotics in particular clinical settings. Heterogeneity and variance in probiotic formulations among trials are among the limitations (26).

Probiotic supplementation significantly reduces the risk and duration of common pediatric illnesses, particularly acute diarrhea and antibiotic-associated diarrhea. Benefits are more pronounced in children under five years and with Lactobacillus strains. Probiotics represent a safe and effective adjunct in pediatric preventive and therapeutic strategies.

1. King S, Glanville J, Sanders ME, Fitzgerald A, Varley D. Effectiveness of probiotics on the duration of illness in healthy children and adults who develop common acute respiratory infectious conditions : a systematic review and meta-analysis British Journal of Nutrition. Br J Nutr. 2014;112:41–54.

2. Vandenplas LD and Y. Probiotics in Pediatrics. A Review and Practical Guide. Nutrients. 2021;13(2176):1–25.

3. Kolaček IH and S. Role of Probiotics in the Treatment and Prevention of Common Gastrointestinal Conditions in Children. Pediatr Gastroenterol Hepatol Nutr. 2024;27(1):1–14.

4. Martinelli M, Banderali G, Bobbio M, Civardi E, Chiara A, Elios SD, et al. Probiotics ’ efficacy in paediatric diseases : which is the evidence ? A critical review on behalf of the Italian Society of Pediatrics. Ital J Pediatr. 2020;46(104):1–13.

5. Farahmandi K, Sulaimany S. Probiotic Effects on Disease Prevention and Treatment. intechopen. 2023;1–23.

6. Ritchie ML, Romanuk TN. A Meta-Analysis of Probiotic Efficacy for Gastrointestinal Diseases. PLOSONE. 2012;7(4):1–11.

7. Cruchet S, Furnes R, Maruy A, Hebel E, Palacios J, Roberto Y, et al. The Use of Probiotics in Pediatric Gastroenterology : A Review of the Literature and Recommendations by Latin-American Experts. Pediatr Drugs. 2015;17:199–216.

8. Hojsak I, Fabiano V, Pop TL, Goulet O, Zuccotti GV, C FC. Guidance on the use of probiotics in clinical practice in children with selected clinical conditions and in specific vulnerable groups. Acta Pædiatrica. 2018;107:927–37.

9. Thomas WR. Efficacy of probiotics in the treatment of allergic diseases : a. Front Nutr. 2025;12(March):1–12.

10. Chen C, Liu P, Xiao L, Cao Q, Zhou D. Probiotics for treating acute diarrhea in children : an evidence synthesis. Front Pediatr. 2026;13(January):1–12.

11. Wang Y, Li X, Ge T, Xiao Y, Liao Y, Zhang Y, et al. Probiotics for prevention and treatment of respiratory tract infections in children. Medicine (Baltimore). 2016;95(31):1–12.

12. Hojsak I. Role of Probiotics in the Treatment and Prevention of Common Gastrointestinal Conditions in Children. Pediatr Gastroenterol Hepatol Nutr. 2024;27(1):1–14.

13. Azad MB, Coneys JG, Kozyrskyj AL, Field CJ, Ramsey CD, Friesen C. Probiotic supplementation during pregnancy or infancy for the prevention of asthma and wheeze : systematic review and meta-analysis. BMJ [Internet]. 2013;347(December):1–15.

14. Chaudhari S, Narola N. A study of hematological parameters in neontal sepsis. Int J Clin Diagnostic Pathol. 2021;4(4):40–4.

15. Wang L, Xu L. The impact of prebiotics , probiotics and synbiotics on the prevention and treatment of atopic dermatitis in children : an umbrella meta-analysis. Front Pediatr [Internet]. 2025;13(March):1–16.

16. Lee J, Seto D, Bielory L. Meta-analysis of clinical trials of probiotics for prevention and treatment of pediatric atopic dermatitis. J ALLERGY CLIN IMMUNOL. 2007;121(1):1–17.

17. Kang E, Kim SY, Hwang I, Ji Y. The Effect of Probiotics on Prevention of Common Cold : A Meta-Analysis of Randomized Controlled Trial Studies. Korean J Fam Med. 2013;34(1):2–10.

18. Bettocchi S, Comotti A, Elli M, Cosmi V De, Berti C, Alberti I, et al. Probiotics and Fever Duration in Children With Upper Respiratory Tract Infections A Randomized Clinical Trial. JAMA Netw Open. 2025;8(3):1–10.

19. Dan W. Thomas FRG. Clinical Report — Probiotics and Prebiotics in Pediatrics. Pediatrics. 2021;126(6):1217–31.

20. Zhang Y, Xu Y, Hu L, Wang X. Advancements related to probiotics for preventing and treating recurrent respiratory tract infections in children. Front Pediatr. 2025;13(February):1–11.

21. Tremblay A, Xu X, Colee J, Tompkins TA. Efficacy of a Multi-Strain Probiotic Formulation in Pediatric Populations : A Comprehensive Review of Clinical Studies. Nutrients. 2021;13(1908):1–19.

22. Kerihuel J, Durand H, Bohbot S, Cazzola M. Efficacy of a synbiotic supplementation in the prevention of common winter diseases in children : a randomized , double-blind , placebo-controlled pilot study. Ther Adv Respir Dis. 2010;4(5):271–8.

23. Steyer A, Miˇ D. The Efficacy of Probiotics as Antiviral Agents for the Treatment of Rotavirus Gastrointestinal Infections in Children : An Updated Overview of Literature. Microorganisms. 2022;10(2392):1–21.

24. Luo X, Wang H, Liu H, Chen Y, Tian L, Ji Q, et al. Effects of probiotics on the prevention and treatment of children with allergic rhinitis: a meta-analysis of randomized controlled trials. Front Pediatr [Internet]. 2024;12(October):1–10.

25. Wang F, Wu F, Chen H, Tang B. The effect of probiotics in the prevention of atopic dermatitis in children : a systematic review and meta-analysis. Transl Pediatr. 2023;12(4):731–48.

26. Garc A, Nieto-ruiz A. Impact of Probiotics on the Prevention and Treatment of Gastrointestinal Diseases in the Pediatric Population. Int J Mol Sci. 2023;24(9427):1–29.